Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-16

FDA Approved: GANIRELIX ACETATE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Ganirelix Acetate as a new generic product under an original ANDA from Lupin Pharmaceuticals to prevent premature ovulation during controlled ovari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganirelix acetate (ganirelix acetate)

Snippet

ORIG AP for GANIRELIX ACETATE (GANIRELIX ACETATE)